Benzazepinones as sodium channel blockers

Details for Australian Patent Application No. 2007258675 (hide)

Owner Merck & Co., Inc.

Inventors Parsons, William H.; Hoyt, Scott B.; London, Clare; Ok, Dong

Agent Spruson & Ferguson

Pub. Number AU-A-2007258675

PCT Pub. Number WO2007/145922

Priority 60/812,402 09.06.06 US

Filing date 5 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/145922 Priority application(s): WO2007/145922

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007258679-Biopsy system with integrated ultrasonic imaging

2007258670-Safety eyewear